Product documentation
Current certificates of analysis from an accredited lab for every SKU, with results that match the label and the claimed THC threshold.
Hemp-derived products are legally distinct from marijuana, and they are underwritten differently too. The decisions that make or break a CBD account are usually about product documentation, website claims and shipping — not about the payment method itself.
CBD and hemp businesses generally can obtain conventional card processing, but through elevated-risk underwriting rather than an ordinary merchant account. The 2018 Farm Bill separated hemp — cannabis containing no more than 0.3% delta-9 THC on a dry weight basis — from marijuana federally, which is why the category is bankable at all.
In practice, approval and survival hinge on four things: whether every product is evidenced by a current certificate of analysis from an accredited lab, whether your website makes any health or therapeutic claim, whether your product mix includes intoxicating hemp-derived cannabinoids that a given sponsor excludes, and whether your shipping and state coverage match your policies. Requirements vary by sponsor and change over time, so treat every point below as something to confirm in writing.
Because hemp is not a federally controlled substance, sponsoring banks can serve the category without the programme obligations that attach to plant-touching marijuana businesses. That widens the set of available payment methods considerably — conventional card acceptance is on the table.
What replaces that constraint is product and claims scrutiny. Sponsors carry regulatory-advertising and consumer-protection exposure, so they read your website as carefully as your bank statements. Two businesses with identical financials get different answers when one makes therapeutic claims and the other does not.
State rules add another layer. Some states restrict specific cannabinoids, product formats or shipping destinations, so your fulfilment footprint becomes part of the underwriting conversation.
Current certificates of analysis from an accredited lab for every SKU, with results that match the label and the claimed THC threshold.
Health, medical, curative or dosage claims are the most common decline trigger. Your site copy is reviewed, not just your application.
Intoxicating hemp-derived cannabinoids are excluded by some sponsors entirely. Your catalogue determines which programmes are even possible.
Where you ship, and whether your policies reflect state restrictions, age verification and refused-destination handling.
Subscription and first-time-buyer models generate disputes. Sponsors care about your dispute ratio and your refund policy's clarity.
Affiliates, influencers and email claims are attributed to you. Sponsors have terminated accounts over affiliate copy the merchant never wrote.
This differs meaningfully from a plant-touching file: less licensing, far more product evidence.
Most hemp declines we see are website declines. Fixing copy before submission is cheaper than reapplying, and it is work you control entirely.
Have your own counsel review claims language. We can tell you what sponsors commonly reject; we cannot tell you what is lawful to say.
Remove or rewrite health, medical and dosage claims across product pages, blogs, email and affiliate copy.
Publish lab results per batch, so a reviewer can verify the catalogue without asking.
Publish refund, shipping, restricted-state and age-verification policies that match what you actually do.
Clear descriptors, visible contact details and honest subscription terms reduce disputes and reviewer concern.
Hemp accounts are most often lost through drift: a new cannabinoid added to the catalogue, an affiliate making a claim, a subscription launch that lifts disputes, or a volume jump nobody flagged.
Businesses that sell both usually need separate arrangements rather than one account. Sponsors underwrite the categories differently, and mixing them in a single catalogue tends to produce the stricter treatment for everything.
The practical approach is clean separation: distinct entities or stores where appropriate, separate product catalogues, separate reporting, and no cross-posting of claims.
How you structure entities and licensing is a legal and tax question for your own advisors. We scope payments around the structure you and your counsel decide.
Where you are today
Not processing yet. We map which payment methods your license type and products can realistically support, what each costs, and what your application file needs before you open.
Plan your payment setupAlready processing but paying too much, funding too slowly, or working around a system that does not fit. Send statements and we return a line-by-line read plus alternatives.
Review my current setupAccount terminated, frozen, capped or moved to reserve. We help you interpret the notice, pursue held funds, and rebuild with fewer single points of failure.
Get help with a complex accountTurned down on application. We read the decline reason, identify what was missing or mismatched in the file — licence, ownership, product mix, banking — and rebuild the submission before it goes back out.
Review a declined applicationHemp-derived CBD sellers are commonly able to obtain card processing through elevated-risk underwriting, because hemp is federally distinct from marijuana under the 2018 Farm Bill. Approval still depends on the sponsor's written policy, your product mix, your lab documentation and your website claims.
The most frequent causes are claims language found during a review, an added cannabinoid or product format outside the sponsor's policy, a dispute ratio above the agreed threshold, or a sponsor exiting the category. Ask for the stated reason in writing, because it determines what you fix before reapplying.
Current certificates of analysis from an accredited laboratory for every SKU, with results consistent with the label and with the applicable THC threshold. Publishing them on the product page reduces friction during review.
Often not. Some sponsors exclude intoxicating hemp-derived cannabinoids entirely, and some states restrict them. Your catalogue determines which programmes are available, so disclose everything you sell up front.
Yes — it is the most common avoidable cause we see. Sponsors read product pages, blogs, email and affiliate copy, and attribute all of it to you. Have counsel review the language before you apply.
Rarely, and it usually results in the stricter treatment applying to everything. Operators selling both typically run separate arrangements with genuinely separated catalogues and reporting.
The separate underwriting environment for CBD and hemp sellers, including online acceptance and product substantiation. These pages sit under this guide and link back to it.
Send your product list, lab documentation and site URLs. We will flag what a reviewer is likely to challenge, identify programmes whose written policy covers your cannabinoids, and tell you what to fix first.
Availability, pricing, funding timelines and account terms depend on your state, license type, product mix, processing history and the underwriting policy of the sponsoring bank or processor. Nothing on this page is legal, tax or compliance advice, a quoted rate, or a promise of approval, card-network acceptance or account continuity. We describe how these arrangements commonly work and tell you what to get in writing.